headway
发表于 2025-3-28 17:29:05
http://reply.papertrans.cn/16/1586/158524/158524_41.png
sinoatrial-node
发表于 2025-3-28 20:05:21
http://reply.papertrans.cn/16/1586/158524/158524_42.png
充气女
发表于 2025-3-29 00:19:07
http://reply.papertrans.cn/16/1586/158524/158524_43.png
调整
发表于 2025-3-29 05:29:40
http://reply.papertrans.cn/16/1586/158524/158524_44.png
纹章
发表于 2025-3-29 08:52:47
Heparin and Low-Molecular Weight Heparins in Thrombosis and Beyond,enzymes, selectin modulation, inhibition of platelet–cancer cell interactions, and inflammatory cell adhesion, help explain the diverse clinical impact of this class of agents in thrombosis and beyond.
synovium
发表于 2025-3-29 14:14:32
http://reply.papertrans.cn/16/1586/158524/158524_46.png
凹处
发表于 2025-3-29 16:43:39
,Praktische Anwendung der Röntgenstrahlen,enzymes, selectin modulation, inhibition of platelet–cancer cell interactions, and inflammatory cell adhesion, help explain the diverse clinical impact of this class of agents in thrombosis and beyond.
欢乐中国
发表于 2025-3-29 21:32:43
Book 2010Latest editionl direct anti-Xa and anti-IIa antagonists, as well as oral antiplatelet ADP antagonists with rapid onset and offset. In addition, there has been concentrated effort aimed at identifying novel uses of traditional antithrombotic drugs, such as aspirin, heparin, and oral anticoagulants, as well as comb
抑制
发表于 2025-3-30 02:54:51
In Vitro Methods of Evaluating Antithrombotics and Thrombolytics, also play a pivotal role in the pathogenesis of arterial thrombotic disorders, including unstable angina (UA), myocardial infarction (MI), and stroke. The underlying pathophysiological mechanism of these processes has been recognized as the disruption or erosion of a vulnerable atherosclerotic plaq
欺骗世家
发表于 2025-3-30 04:14:52
In Vivo Models for the Evaluation of Antithrombotics and Thrombolytics,e selection of new agents for clinical evaluation, and have informed dosing and safety information for clinical trials. These models also provide valuable information about the mechanisms of action/interaction of new antithrombotic agents. Small and large animal models of thrombosis and their role i